Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Daratumumab
Daratumumab
Medicine
PIL
SPC
XPIL
Legal Category
Active Ingredient(s)
Company
DARZALEX 1,800 mg solution for injection
PIL
24/03/23
SPC
20/03/24
No
A
Daratumumab
Janssen Sciences Ireland
DARZALEX 20 mg/mL concentrate for solution for infusion.
PIL
03/11/23
SPC
20/03/24
No
A
Daratumumab
Janssen Sciences Ireland
Cookies
Direct Healthcare Professional Communications
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)